SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-13-003322
Filing Date
2013-08-09
Accepted
2013-08-09 16:15:34
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080913.htm 10-Q 1558306
2 EXHIBIT 31.1 exh_311.htm EX-31.1 13402
3 EXHIBIT 31.2 exh_312.htm EX-31.2 13280
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5374
5 EXHIBIT 32.2 exh_322.htm EX-32.2 5248
  Complete submission text file 0001171843-13-003322.txt   16459433

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scmp-20130630.xml EX-101.INS 2731189
7 XBRL TAXONOMY EXTENSION SCHEMA scmp-20130630.xsd EX-101.SCH 61253
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scmp-20130630_cal.xml EX-101.CAL 45921
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scmp-20130630_def.xml EX-101.DEF 275767
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scmp-20130630_lab.xml EX-101.LAB 433141
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scmp-20130630_pre.xml EX-101.PRE 286553
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 131026793
SIC: 2834 Pharmaceutical Preparations